Geopolitics Alpha

8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Dermata Therapeutics filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
  • Exposed: DRMA
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Dermata Therapeutics, Inc.(0001853816) (Filer)DRMAGEOPOLITICS ALPHA

8-K - Dermata Therapeutics filed an 8-K with the SEC on Nov 17 (a notice of a material company event).

Directly affected

  • DRMA Dermata Therapeutics-15.9% 9d

    Named in this report.

Indirectly affected

  • No related companies are mapped for this report yet.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
DRMA+21.04%+20.29%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-17 AccNo: 0001493152-26-052715 Size: 199 KB Item 8.01: Other Events

Source: sec-edgar

How far Dermata Therapeutics (DRMA) has moved since 17 Nov 2026

CompanyWhenMoveStatus
Dermata Therapeutics (DRMA)three days earlier+20.29%final price
Dermata Therapeutics (DRMA)five days earlier+21.04%final price

Who gains and who loses around Dermata Therapeutics (DRMA)

Companies carried with this story

  • DRMA Dermata Therapeutics

    In “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer),” Dermata Therapeutics (DRMA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DRMA

How “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)” reaches Dermata Therapeutics (DRMA)

Dermata Therapeutics (DRMA) is the company in “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer),” the 17 Nov 2026 this story story.

For Dermata Therapeutics (DRMA), the reason on file says SEC 8-K filing -> direct issuer disclosure -> DRMA

Price levels for Dermata Therapeutics (DRMA)

DRMA traded between 0.71 and 0.91 across 9 sessions. The latest close on file is 0.71.

How strong the case is around Dermata Therapeutics (DRMA)

14 out of 100

“8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.